Promoter Jay Arvind Bhanushali Acquires 0.23% Stake in Aspira Pathlab via Open Market
Aspira Pathlab & Diagnostics Ltd 路 Acquisition/ Disposal of Shares 路 18 Nov 2026, 4:27 pm
Promoter Jay Arvind Bhanushali Acquires 0.23% Stake in Aspira Pathlab via Open Market Promoter Jay Arvind Bhanushali acquired 23,834 equity shares, representing a 0.23% stake, in Aspira Pathlab & Diagnostics Ltd via open market transactions between 16th Nov'26 and 17th Nov'26. Following the acquisition, his shareholding in the company increased from 7,52,395 equity shares (7.31%) to 7,76,229 equity shares (7.54% of total voting capital). The total equity share capital remains unchanged at Rs 10.29 cr divided into 1.03 cr equity shares of Rs 10 each.
Original exchange filing (PDF)
More announcements from Aspira Pathlab & Diagnostics Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- Enclosed herewith Financial Result for the Half Year ended 30th September 2026 路 06 Nov 2026
- Enclosed herewith Board Meeting Outcomes dated 6th November 2026 路 06 Nov 2026
- Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Un-audited Financial .... 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 01 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 28 Sept 2026
- Disclosure of Voting Results of 53rd Annual General Meeting along with the Scrutinizer Report 路 26 Sept 2026
